Asia-Pacific stocks fall as U.S. 10-12 months Treasury yield notches 16-12 months high

Asia-Pacific stocks fall as U.S. 10-12 months Treasury yield notches 16-12 months high


Mount Fuji and buildings in the Shinjuku district are reflected on a desk at an observation deck in Tokyo, Japan, on December 24, 2013.

Kiyoshi Ota | Bloomberg | Getty Images

Asia-Pacific markets opened lower soon after the U.S. 10-yr Treasury yield strike its best stage in 16 years.

Australia’s S&P/ASX 200 fell .42%.

In Japan, Nikkei 225 dropped 1.45% in its to start with hour of trade, even though the Topix was 1.31% decrease. South Korea’s Kospi fell 1.19% and the Kosdaq slipped 1.17% following coming again from holiday.

Hong Kong’s Dangle Seng index is in the same way poised for a dip with futures at 17,322 in comparison to the HSI’s shut of 17,331.22.



Source

Tesla reports 358,000 first-quarter vehicle deliveries, down 14% from last quarter
World

Tesla reports 358,000 first-quarter vehicle deliveries, down 14% from last quarter

Tesla posted its vehicle deliveries and production report for the first quarter of 2026, showing a drop from the prior period but mild growth from a year earlier. Tesla has recorded annual declines in the past two years. Here are the key numbers: Total Q1 vehicle deliveries: 358,023 Total Q1 vehicle production: 408,386 Analysts were […]

Read More
Countries are rethinking retirement systems – here’s what that means
World

Countries are rethinking retirement systems – here’s what that means

By 2050, there will be 52 people aged 65 and over for every 100 working-age adults, increasing pressure on pension systems worldwide. Governments are responding by reshaping retirement systems — from shifting investment strategies to improving long-term sustainability. But progress is uneven, and where you live could have a significant impact on your retirement security. […]

Read More
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
World

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly‘s rival pill that was approved this week, Novo Nordisk said Thursday.  Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under the […]

Read More